Lido Advisors, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Lido Advisors, LLC

$20.3 Billion
Q3 2024

A detailed history of Lido Advisors, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Lido Advisors, LLC holds 22,008 shares of CPRX stock, worth $496,280. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,008

Previous 14,719 49.52%

Holding current value

$496,280

Previous $227,000 92.51%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.19 - $21.35 $110,719 - $155,620	7,289 Added 49.52%	22,008 $437,000
Q2 2024 Aug 14, 2024	BUY	$14.68 - $16.92 $1,101 - $1,269	75 Added 0.51%	14,719 $227,000
Q1 2024 May 15, 2024	SELL	$13.18 - $17.11 $11,097 - $14,406	-842 Reduced 5.44%	14,644 $233,000
Q4 2023 Feb 14, 2024	BUY	$11.78 - $17.29 $50,359 - $73,914	4,275 Added 38.13%	15,486 $260,000
Q3 2023 Nov 14, 2023	SELL	$11.69 - $15.02 $273,744 - $351,723	-23,417 Reduced 67.62%	11,211 $131,000
Q2 2023 Aug 09, 2023	SELL	$11.5 - $18.08 $130,732 - $205,533	-11,368 Reduced 24.72%	34,628 $465,000
Q1 2023 May 15, 2023	BUY	$14.34 - $21.05 $481,780 - $707,216	33,597 Added 270.97%	45,996 $762,000
Q4 2022 Feb 14, 2023	SELL	$12.25 - $19.5 $68,563 - $109,141	-5,597 Reduced 31.1%	12,399 $230,000
Q3 2022 Nov 14, 2022	SELL	$7.06 - $15.52 $4,638 - $10,196	-657 Reduced 3.52%	17,996 $230,000
Q2 2022 Aug 15, 2022	SELL	$6.23 - $8.57 $100,788 - $138,645	-16,178 Reduced 46.45%	18,653 $130,000
Q1 2022 May 17, 2022	BUY	$5.31 - $8.31 $19,408 - $30,373	3,655 Added 11.72%	34,831 $288,000
Q4 2021 Feb 15, 2022	SELL	$5.21 - $7.45 $205,586 - $293,977	-39,460 Reduced 55.86%	31,176 $211,000
Q3 2021 Nov 12, 2021	BUY	$4.85 - $6.04 $161,422 - $201,029	33,283 Added 89.1%	70,636 $374,000
Q2 2021 Aug 12, 2021	SELL	$4.29 - $6.05 $76,923 - $108,482	-17,931 Reduced 32.43%	37,353 $215,000
Q1 2021 May 13, 2021	BUY	$3.45 - $4.69 $122,792 - $166,926	35,592 Added 180.74%	55,284 $255,000
Q3 2020 Nov 12, 2020	SELL	$2.97 - $5.08 $19,340 - $33,080	-6,512 Reduced 24.85%	19,692 $58,000
Q2 2020 Aug 12, 2020	SELL	$3.48 - $5.05 $2,505 - $3,636	-720 Reduced 2.67%	26,204 $121,000
Q1 2020 May 13, 2020	SELL	$2.61 - $5.21 $3,372 - $6,731	-1,292 Reduced 4.58%	26,924 $104,000
Q4 2019 Feb 07, 2020	SELL	$3.67 - $5.7 $4,315 - $6,703	-1,176 Reduced 4.0%	28,216 $106,000
Q3 2019 Nov 12, 2019	SELL	$3.89 - $7.43 $221,387 - $422,856	-56,912 Reduced 65.94%	29,392 $156,000
Q2 2019 Aug 14, 2019	SELL	$2.7 - $6.11 $108,267 - $245,004	-40,099 Reduced 31.72%	86,304 $331,000
Q1 2019 May 10, 2019	BUY	$2.11 - $5.33 $28,231 - $71,315	13,380 Added 11.84%	126,403 $644,000
Q4 2018 Feb 14, 2019	BUY	$1.92 - $3.62 $24,610 - $46,401	12,818 Added 12.79%	113,023 $217,000
Q3 2018 Nov 14, 2018	BUY	$2.81 - $3.78 $35,684 - $48,002	12,699 Added 14.51%	100,205 $378,000
Q2 2018 Aug 14, 2018	BUY	$2.26 - $3.84 $62,751 - $106,621	27,766 Added 46.48%	87,506 $273,000
Q1 2018 May 10, 2018	BUY	$2.39 - $4.01 $142,778 - $239,557	59,740 New	59,740 $142,000

Others Institutions Holding CPRX

# of Institutions

330

Shares Held

94.7M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.32B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.

Account

Lido Advisors, LLC Catalyst Pharmaceuticals, Inc. Transaction History